lobbying_activities: 2821452

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2821452	57b4971e-430e-4cff-aa6b-786e11e1e783	Q2	REINECKE STRATEGIC SOLUTIONS, INC.	298012	PHARMAVITE LLC	2022	second_quarter	CSP	Regulation of dietary supplements and natural products. Specifically related to mandatory product listing and increased authority for FDA to combat illegal supplements. S. 1698 and H.R. 841 to provide for regulation of CBD products. S.4090, Dietary Supplement Listing Act. S. 4348, FDASLA Act of 2022. SHOP SAFE Act H.R. 3429/S.1843. INFORM Consumers Act S. 936. America Competes Act of 2022, H.R. 4521.	HOUSE OF REPRESENTATIVES,SENATE	40000		0	0	2022-07-15T21:49:12-04:00